EpiThany Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private

EpiThany General Information


Developer of an anti-cancer immunotherapy treatment intended to treat patients with solid tumors. The company's immunotherapy focuses on developing tumor vaccines that drive Th1 (tumor-eradicating) immune responses without stimulating competitive Th2 (tumor-tolerant) responses, enabling physicians to target myriad tumor antigens across a spectrum of cancers, yielding a deep pipeline of Th1-selective anti-cancer vaccines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 3240 Fuhrman Avenue East
  • Suite 106
  • Seattle, WA 98102
  • United States
+1 (206) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiThany Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Generating Revenue
1. Later Stage VC Completed Clinical Trials - Phase 1
To view EpiThany’s complete valuation and funding history, request access »

EpiThany Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of an anti-cancer immunotherapy treatment intended to treat patients with solid tumors. The company's immunoth
Drug Discovery
Seattle, WA
000000 - 000


irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000 000000000
Rockville, MD
00 As of 0000
0000000000 0 00000

000000 0

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
Plymouth Meeting, PA
000 As of 0000
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiThany Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immunomic Therapeutics Venture Capital-Backed Rockville, MD 00 00000 0000000000 0 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000000 000 Formerly VC-backed Emeryville, CA 000 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

EpiThany Executive Team (3)

Name Title Board Seat Contact Info
William Watt Ph.D Co-Founder, Chief Executive Officer, President & Board Member
David Poston Chief Operating Officer
Mary Disis MD Scientific Co-Founder
To view EpiThany’s complete executive team members history, request access »

EpiThany Board Members (3)

Name Representing Role Since
Martin Simonetti Sr. Self Board Member 000 0000
Michael Gallatin Ph.D EpiThany Board Member 000 0000
William Watt Ph.D EpiThany Co-Founder, Chief Executive Officer, President & Board Member 000 0000
To view EpiThany’s complete board members history, request access »